UNSPSC 51162744: Tetrahydrozoline or tetryzoline

This classification denotes an alpha-adrenergic agonist with the molecular formula C13H16N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S9U025Y077, chemically known as 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-1h-imidazole but more generally known as tetrahydrozoline, which bears US NIH Compound Identifier 5419. European Medicines Agency schedules Tetryzoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10955MIG.

UNSPSC 51162744 Tetrahydrozoline or tetryzoline, a Commodity code, covers pharmaceutical agents used in clinical and correctional health settings, though recent state and local solicitation activity under this code is sparse and shows limited direct relevance. The Washington State Department of Corrections RFQ RFQQK13020 posted September 8, 2026, solicits parenteral products, services, and equipment for eight correctional facilities across Washington, including IV solutions, parenteral nutrition preparations, and other injectable products for incarcerated individuals—a broad scope that nominally encompasses tetrahydrozoline but treats it as one component within a much larger parenteral-products portfolio rather than a standalone procurement focus. The Seminole County, Florida IFB60459723LAS posted June 30, 2026, targets naloxone and drug deactivation systems for community health, which falls outside the tetrahydrozoline commodity scope and appears to be a source-tagging error. Issuing bodies engaging under this code include state correctional departments and county health authorities, though the limited recent opportunities make characterization of the buyer base difficult. Washington State represents the most recent documented activity at the state level.

Geographic activity centers on Washington and Florida based on the two posted opportunities, though the data set is too narrow to establish a reliable regional concentration. The Washington State Department of Corrections RFQ RFQQK13020 closes October 7, 2026, and anticipates awarding up to three contractors per region across West, Central, and East facility clusters, with contract performance running November 26, 2026 through June 30, 2030 and fixed pricing through the initial two-year term; DOC encourages small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation. The Seminole County opportunity closed July 26, 2023, and is not current. The code shows limited recent state and local procurement momentum; most tetrahydrozoline demand appears bundled within broader parenteral-products contracts rather than solicited as a discrete commodity line.